Description
MYOVIEW MODIFICATION P00003 ISSUED TO DECREASE FUNDING FOR CONTRACT FOLDER CLOSEOUT
Base award description: MYOVIEW
Modification chain · 4 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2014-04-04+$19,100= $19,100
- Mod P000012014-04-15+$0= $19,100
- Mod P000022014-07-02-$34= $19,066
- Mod P000032015-09-23-$3,315= $15,751
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2014-04-04 | +$19,100 | $19,100 | MYOVIEW |
| Mod P00001· CHANGE ORDER | 2014-04-15 | +$0 | $19,100 | MYOVIEW |
| Mod P00002· FUNDING ONLY ACTION | 2014-07-02 | −$34 | $19,066 | MYOVIEW MODIFICATION P00001 ISSUED TO CORRECT LINE ITEM DESCRIPTION AND ADD DELIVERY CHARGE LINE ITME TO ORDER… |
| Mod P00003· FUNDING ONLY ACTION | 2015-09-23 | −$3,315 | $15,751 | MYOVIEW MODIFICATION P00003 ISSUED TO DECREASE FUNDING FOR CONTRACT FOLDER CLOSEOUT |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI CETPVZL5RQS3)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C25926N0409 | NETWORK CONTRACT OFFICE 19 (36C259) · 6505 · DRUGS AND BIOLOGICALS | $34,735 | FY2026 |
| 36C24826N0693 | 248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS | $111,150 | FY2026 |
| 36C25226N0456 | 252-NETWORK CONTRACT OFFICE 12 (36C252) · 6505 · DRUGS AND BIOLOGICALS | $34,735 | FY2026 |
| 36C26326F0080 | NETWORK CONTRACT OFFICE 23 (36C263) · 6505 · DRUGS AND BIOLOGICALS | $27,788 | FY2026 |
| 36C25726N0272 | 257-NETWORK CONTRACT OFFICE 17 (36C257) · 6505 · DRUGS AND BIOLOGICALS | $257,789 | FY2026 |
| 36C25726D0056 | 257-NETWORK CONTRACT OFFICE 17 (36C257) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2026 |
Other recipients under 6505 from 550-DANVILLE (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA25116F0523 | CSL BEHRING L.L.C. | 550-DANVILLE | $413 | FY2016 |
| VA25115J1796 | NOVARTIS VACCINES AND DIAGNOSTICS, INC. | 550-DANVILLE | $15,600 | FY2015 |
| VA25115J1790 | NOVARTIS VACCINES AND DIAGNOSTICS, INC. | 550-DANVILLE | $55,380 | FY2015 |
| VA25114F0296 | CEPHEID | 550-DANVILLE | $26,029 | FY2014 |
| VA25113P1590 | TOBII DYNAVOX LLC | 550-DANVILLE | $7,942 | FY2013 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA25114F1488_3600_V797D30202_3600 · retrieved 2026-09-26.